First prescription, documentation, and follow up

• The full visit history should be completed / updated on NaSH.
• Written method information or SMS link/leaflet including information about actions after missed pills, ring or patch and a contact number is given to client.
• Record prescription on NaSH
• Nurse supplying where appropriate under patient group direction.
• Consider notifying GP of prescription, if permission is given for correspondence

At first prescription of CHC, all women should be informed that CHC use is safe for the majority but can be associated with rare but serious harms. Discuss the risks as found in Indications, efficacy, side-effects, and risks

Return visit

• Women should be encouraged to attend their GP for follow up and ongoing supply of CHC.
• A 12 month supply (except for NuvaRing) may be issued to clients at the initial visit, and thereafter provided no problems have been identified.
• Nuvaring must be used within 4 months after dispensing. Clients should therefore only be issued with a 3 month supply at any visit. Even with extended use, no more than one box of 3 rings can be issued at one time.